• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    7/21/23 1:24:14 PM ET
    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACGN alert in real time by email

     

    On Friday, 54 companies hit new 52-week lows.

    Areas of Interest About Today's 52-Week Lows:

    • NovoCure (NASDAQ:NVCR) is the largest company in terms of market cap to set a new 52-week low this morning.
    • Ucommune International (NASDAQ:UK) was the smallest company by market cap to set a new 52-week low.
    • Sigma Additive Solutions (NASDAQ:SASI) saw the largest move of the companies, as shares plummetted 27.56% to hit a new 52-week low.
    • Greenbrook TMS (NASDAQ:GBNH) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    On Friday, the following stocks broke to new 52-week lows:

    • NovoCure (NASDAQ:NVCR) stock achieved a new 52-week low on Friday morning, hitting $38.15 and moving up 0.85%.
    • Sensient Technologies (NYSE:SXT) shares were down 6.61% for the day, having made a 52-week low of $62.86.
    • Mirati Therapeutics (NASDAQ:MRTX) stock dropped to a yearly low on Friday of $28.20. Shares traded down 8.19%.
    • Star Bulk Carriers (NASDAQ:SBLK) stock hit $16.57 on Friday morning, setting a new 52-week low for a change of down 2.79%.
    • Methode Electronics (NYSE:MEI) shares hit a yearly low of $31.99. The stock was down 0.46% on the session.
    • AnaptysBio (NASDAQ:ANAB) stock hit a new 52-week low of $17.96. The stock was down 2.26% on the session.
    • uniQure (NASDAQ:QURE) stock set a new 52-week low of $9.75 on Friday, moving down 0.85%.
    • Enanta Pharma (NASDAQ:ENTA) stock hit a yearly low of $18.24. The stock was down 1.39% for the day.
    • Funko (NASDAQ:FNKO) shares moved down 2.73% on Friday to hit a new 52-week low of $6.88, drifting down 2.73%.
    • FibroGen (NASDAQ:FGEN) shares were down 3.11% for the day, having made a 52-week low of $2.10.
    • Inogen (NASDAQ:INGN) shares moved down 2.26% on Friday to hit a new 52-week low of $8.35, drifting down 2.26%.
    • Altimmune (NASDAQ:ALT) shares moved down 1.1% on Friday to hit a new 52-week low of $3.09, drifting down 1.1%.
    • G1 Therapeutics (NASDAQ:GTHX) stock drifted up 0.21% on Friday morning to hit a new 52-week low of $2.35.
    • ADC Therapeutics (NYSE:ADCT) shares set a new 52-week low of $1.41. The stock traded down 5.4%.
    • OrganiGram Holdings (NASDAQ:OGI) shares made a new 52-week low of $1.30 on Friday. The stock was down 2.22% for the day.
    • Birks Group (AMEX:BGI) shares were up 0.22% for the day, having made a 52-week low of $4.60.
    • Dare Bioscience (NASDAQ:DARE) stock hit a new 52-week low of $0.76. The stock was down 1.47% on the session.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) shares set a new 52-week low of $1.48. The stock traded down 8.48%.
    • Airgain (NASDAQ:AIRG) shares set a new yearly low of $4.78 this morning. The stock was down 2.0% on the session.
    • Lichen China (NASDAQ:LICN) shares moved down 0.85% on Friday to hit a new 52-week low of $1.14, drifting down 0.85%.
    • USD Partners (NYSE:USDP) shares moved down 0.02% on Friday to hit a new 52-week low of $0.77, drifting down 0.02%.
    • Palatin Techs (AMEX:PTN) stock hit a yearly low of $1.91. The stock was down 4.9% for the day.
    • Aspira Womens Health (NASDAQ:AWH) shares fell to $2.51 on Friday, setting a new 52-week low with a shift of down 7.63%.
    • Vaccinex (NASDAQ:VCNX) shares reached a new 52-week low of $0.28 on Friday morning, moving down 1.38%.
    • Globus Maritime (NASDAQ:GLBS) shares set a new yearly low of $0.68 this morning. The stock was up 0.29% on the session.
    • Cadrenal Therapeutics (NASDAQ:CVKD) shares set a new 52-week low of $1.16. The stock traded down 6.47%.
    • IronNet (NYSE:IRNT) stock drifted down 6.47% on Friday morning to hit a new 52-week low of $0.12.
    • ShiftPixy (NASDAQ:PIXY) shares made a new 52-week low of $1.10 on Friday. The stock was down 6.2% for the day.
    • Greenbrook TMS (NASDAQ:GBNH) shares moved 0.0% (flat) on Friday to hit a new 52-week low of $0.31, drifting 0.0% (flat).
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares were down 3.98% for the day, having made a 52-week low of $0.94.
    • Fangdd Network Group (NASDAQ:DUO) stock dropped to a yearly low on Friday of $0.17. Shares traded down 9.25%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock dropped to a yearly low on Friday of $0.32. Shares traded down 4.13%.
    • ViewRay (NASDAQ:VRAY) stock broke to a new 52-week low of $0.05 on Friday. Shares of the company traded down 14.17%.
    • Precipio (NASDAQ:PRPO) shares fell to $0.32 on Friday, setting a new 52-week low with a shift of down 1.23%.
    • Aceragen (NASDAQ:ACGN) shares set a new 52-week low of $1.00. The stock traded down 17.1%.
    • Titan Pharma (NASDAQ:TTNP) shares set a new 52-week low of $0.53. The stock traded down 1.96%.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) shares fell to $4.22 on Friday, setting a new 52-week low with a shift of down 5.26%.
    • Micromobility com (NASDAQ:MCOM) shares moved down 6.22% on Friday to hit a new 52-week low of $0.09, drifting down 6.22%.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) stock achieved a new 52-week low on Friday morning, hitting $1.80 and moving down 5.47%.
    • Netcapital (NASDAQ:NCPL) stock achieved a new 52-week low on Friday morning, hitting $0.64 and moving down 5.15%.
    • Phio Pharma (NASDAQ:PHIO) shares hit a yearly low of $2.61. The stock was down 0.52% on the session.
    • SuperCom (NASDAQ:SPCB) stock hit $0.80 on Friday morning, setting a new 52-week low for a change of down 4.06%.
    • Kiora Pharmaceuticals (NASDAQ:KPRX) shares moved down 2.05% on Friday to hit a new 52-week low of $0.58, drifting down 2.05%.
    • Novan (NASDAQ:NOVN) shares made a new 52-week low of $0.12 on Friday. The stock was down 15.99% for the day.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a yearly low of $1.01. The stock was down 5.5% for the day.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) stock hit $1.15 on Friday morning, setting a new 52-week low for a change of down 6.05%.
    • Ucommune International (NASDAQ:UK) stock broke to a new 52-week low of $0.35 on Friday. Shares of the company traded down 3.8%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACGN
    $ADCT
    $ADMP
    $AIRG

    CompanyDatePrice TargetRatingAnalyst
    uniQure N.V.
    $QURE
    1/28/2026$31.00Equal Weight
    Barclays
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Airgain Inc.
    $AIRG
    1/21/2026$6.00Buy
    Lake Street
    AnaptysBio Inc.
    $ANAB
    1/7/2026$70.00Buy
    UBS
    Palatin Technologies Inc.
    $PTN
    12/12/2025$60.00Buy
    Laidlaw
    Palatin Technologies Inc.
    $PTN
    12/3/2025$50.00Buy
    Alliance Global Partners
    Enanta Pharmaceuticals Inc.
    $ENTA
    11/14/2025Overweight
    Analyst
    More analyst ratings

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on uniQure with a new price target

    Barclays initiated coverage of uniQure with a rating of Equal Weight and set a new price target of $31.00

    1/28/26 7:20:10 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Altimmune with a new price target

    Barclays initiated coverage of Altimmune with a rating of Overweight and set a new price target of $20.00

    1/28/26 7:15:18 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $488 worth of shares (25 units at $19.50), increasing direct ownership by 3% to 995 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:21:46 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $505 worth of shares (31 units at $16.30), increasing direct ownership by 3% to 970 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:19:49 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

    ~ Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~ ~ Stable Lyso-Gb3 levels maintained post-dosing, regardless of enzyme replacement therapy status across all cohorts ~ ~ Six of 11 patients have discontinued enzyme replacement therapy as of data cutoff date ~ LEXINGTON, Mass. and AMSTERDAM, Feb. 06, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced updated preliminary safety and exploratory efficacy data from 11 patients in its Phase I/IIa trial of AMT-191, an investigational AAV gene

    2/6/26 7:05:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anaptys Announces Participation at Upcoming Investor Conferences

    SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Guggenheim Emerging Outlook: Biotech Summit 2026, New York, NY Format – Fireside chat and 1x1 investor meetingsDate and Time – Wednesday, Feb. 11, 2026 at 3:00pm ET Piper Sandler Virtual Novel Targets in Immunology Symposium, Virtual Format – Fireside chatDate and Time – Thursday, Feb. 12, 2026 at 12:30pm ET

    2/5/26 4:15:00 PM ET
    $ANAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Airgain Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, February 26, at 5:00 p.m. ET

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, will hold a conference call on Thursday, February 26, 2026, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Airgain management will host the presentation, followed by a question-and-answer period. Date: Thursday, February 26, 2026 Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time) Participant Dial-In: 877-407-2988 / +1 201-389-0923 or Call Me Event Confirmation #: 13757859 The conference call will be broadcast simultaneously and available for replay via the investor section of the company's website

    2/5/26 8:00:00 AM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    SEC Filings

    View All

    SEC Form 8-K filed by Netcapital Inc.

    8-K - Netcapital Inc. (0001414767) (Filer)

    2/6/26 4:30:23 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    SEC Form S-8 filed by Altimmune Inc.

    S-8 - Altimmune, Inc. (0001326190) (Filer)

    2/6/26 4:07:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Enanta Pharmaceuticals Inc.

    SCHEDULE 13G/A - ENANTA PHARMACEUTICALS INC (0001177648) (Subject)

    2/5/26 2:48:42 PM ET
    $ENTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lockshin Curtis was granted 16,600 shares, increasing direct ownership by 89% to 35,155 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 8:01:09 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Freeman Jonathan E was granted 16,600 shares, increasing direct ownership by 103% to 32,655 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 8:00:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Deming David H was granted 23,800 shares, increasing direct ownership by 170% to 37,800 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 7:59:20 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Leadership Updates

    Live Leadership Updates

    View All

    Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

    Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026 at the Borgata Hotel in Atlantic City, NJ.Robert Bitterman, CEO and Chairman of the Board of Phio Pharmaceuticals will deliver a company presentation on January 28th at 9 AM in Borgata Hotel Room #1 and the management team will be avai

    1/26/26 8:15:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, today announced that it has granted inducement awards to one new employee who recently joined the Company. The awards were made on December 15, 2025, under Airgain's 2021 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Airgain as an inducement to join the company. The inducement awards to the new employee consist of an aggregate of 1,150 restricted stock units ("RSUs"). The RSUs shall vest over four years in substantially equal annual installments on December 15, 2026, 2027, 2028, and 2029, subject to the employee's continued service

    12/15/25 4:05:00 PM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Netcapital Inc. Announces Appointment of Rich Wheeless as CEO

    NCPL to Expand Beyond Traditional Securities into Crypto and Blockchain-Enabled Investments BOSTON, MA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a digital private capital markets ecosystem, today announced the appointment of Rich Wheeless as CEO. Former CEO, Martin Kay, will remain as an advisor to the company. Mr. Wheeless is a seasoned executive with more than 20 years of financial leadership and corporate management experience across multiple industries in both public and private enterprises. He was most recently the Chief Executive Officer of a publicly traded logistics and warehousing solutions company and has served as an active inves

    12/8/25 5:00:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Financials

    Live finance-specific insights

    View All

    Airgain Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, February 26, at 5:00 p.m. ET

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, will hold a conference call on Thursday, February 26, 2026, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Airgain management will host the presentation, followed by a question-and-answer period. Date: Thursday, February 26, 2026 Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time) Participant Dial-In: 877-407-2988 / +1 201-389-0923 or Call Me Event Confirmation #: 13757859 The conference call will be broadcast simultaneously and available for replay via the investor section of the company's website

    2/5/26 8:00:00 AM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sensient Announces Conference Call

    Sensient Technologies Corporation (NYSE:SXT) will hold its earnings call and webcast to discuss 2025 fourth quarter and year-end results at 8:30 a.m. CST on Friday, February 13, 2026. Investors may access the live webcast on the Company's web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company's web site following the call. The call transcript will be available on the Company's web site on or after February 18, 2026. About Sensient Technologies Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, fl

    1/30/26 4:05:00 PM ET
    $SXT
    Major Chemicals
    Industrials

    $ACGN
    $ADCT
    $ADMP
    $AIRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care